Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MPO's Most-Read Stories This Week—Dec. 11 - Medical Product Outsourcing

What are you searching for?

Sign in

MPO’s Most-Read Stories This Week—Dec. 11

A listing of the most popular items from the past seven days.

By: Michael Barbella

Managing Editor, Rodman Media

Business news dominated readers’ attention this week amid a flurry of acquisitions and partnerships. BD led the pack, revealing the name of its independent, publicly-traded Diabetes Care business (“embecta”), and announcing the purchase of privately-held Tissuemed Ltd., a Leeds, England-based developer of self-adhesive surgical sealant films. The new business name represents BD’s commitment to diabetes patients and its corporate heritage: the “em” prefix evokes sympathy for those living with diabetes as well as the empowerment of the new firm to seek new avenues of growth, while the “bect” embodies the BD spirit by embedding part of its legacy brand—the “bect” from Becton, Dickinson and Company. 

Other M&A-related news popular with website visitors included Thermo Fisher Scientific’s closing of its $17.4 billion PPD deal, a purchase first announced in April. The acquisition is expected to contribute about $1.50 to Thermo Fisher’s adjusted earnings per share next year.

The Thermo Fisher-PPD deal closing followed Venus Medtech’s $300 million bid for Israeli transcatheter mitral and tricuspid valve treatment company Cardiovalve the previous day (Dec. 7). China-based Venus Medtech said the deal will enhance its product pipeline in the cardiac valve disease treatment area and accelerate its expansion into international markets.  


1. BD Chooses ’embecta’ for Name of Diabetes Biz Spinoff


2. Thermo Fisher Closes $17.4B Deal for PPD 


3. BD Buys Tissuemed, Gains Advanced Surgical Sealant


4. Venus Medtech to Buy Cardiovalve for $300M


5. Dentsply Sirona, 3Shape Expand Strategic Partnership

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters